ArticleBMC complementary and alternative medicine2005
Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City.
Article in BMC complementary and alternative medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review.BMC public health · 2012Pooled it
- Complementary and alternative medicine use in coronary heart disease patients: a cross-sectional study from Palestine.BMC complementary medicine and therapies · 2020Article
- Somatic symptoms in women with dysmenorrhea and noncyclic pelvic pain.Archives of women's mental health · 2018Article
- Complementary and alternative medicine use amongst patients with cardiovascular disease in Singapore.BMC complementary and alternative medicine · 2016Article
- Feasibility and potential benefit of collecting Complementary and Alternative Medicine data through a computerized patient interview.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2011Article
- Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease.Evidence-based complementary and alternative medicine : eCAM · 2011Article
- Use of complementary and alternative medicine and self-tests by coronary heart disease patients.BMC complementary and alternative medicine · 2008Article
- Self-care and adherence to medication: a survey in the hypertension outpatient clinic.BMC complementary and alternative medicine · 2008Article
- Dietary supplements, herbs and oral anticoagulants: the nature of the evidence.Journal of thrombosis and thrombolysis · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of complementary and alternative products including Biological Based Therapy (BBT) has increased among patients with various medical illnesses and conditions. The studies assessing the prevalence of BBT use among patients with cardiovascular diseases are limited. Therefore, an evaluation of BBT in this patient population would be beneficial. This was a survey designed to determine the effects of demographics on the use of Biological Based Therapy (BBT) in patients with cardiovascular diseases. The objective of this study was to determine the effect of the education level on the use of BBT in cardiovascular patients. This survey also assessed the perceptions of users regarding the safety/efficacy of BBT, types of BBT used and potential BBT-drug interactions.
methodThe survey instrument was designed to assess the findings. Patients were interviewed from February 2001 to December 2002. 198 inpatients with cardiovascular diseases (94 BBT users and 104 non-users) in a university hospital were included in the study.
resultsUsers had a significantly higher level of education than non-users (college graduate: 28 [30%] versus 12 [12%], p = 0.003). Top 10 BBT products used were vitamin E [41(43.6%)], vitamin C [30(31.9%)], multivitamins [24(25.5%)], calcium [19(20.2%)], vitamin B complex [17(18.1%)], fish oil [12(12.8%)], coenzyme Q10 [11(11.7%)], glucosamine [10(10.6%)], magnesium [8(8.5%)] and vitamin D [6(6.4%)]. Sixty percent of users' physicians knew of the BBT use. Compared to non-users, users believed BBT to be safer (p < 0.001) and more effective (p < 0.001) than prescription drugs. Forty-two potential drug-BBT interactions were identified.
conclusionIncidence of use of BBT in cardiovascular patients is high (47.5%), as is the risk of potential drug interaction. Health care providers need to monitor BBT use in patients with cardiovascular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.